SHSimon Holliday

Simon Holliday

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simon Holliday has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protecting Pain Patients. The Evaluation of a Chronic Pain Educational Intervention

    by Simon Holliday, Chris Hayes, Adrian Dunlop, Simon Morgan, Amanda Tapley, Kim Henderson, Briony Larance, Parker Magin

    Advocacy and commercially funded education successfully reduced barriers to the provision of long-term opioid analgesia. The subsequent escalation of opioid prescribing for chronic noncancer pain has seen increasing harms without improved pain outcomes. This was a one-group pretest-posttest design study. A multidisciplinary team developed a chronic pain educational package for general practitioner trainees emphasizing limitations, risk-mitigation, and deprescribing of opioids with transition to active self-care. This educational intervention incorporated prereadings, a resource kit, and a 90-minute interactional video case-based workshop incorporated into an education day. Evaluation was via pre- and postintervention (two months) questionnaires. Differences in management of two clinical vignettes were tested using McNemar’s test. Of 58 eligible trainees, 47 (response rate = 81.0%) completed both questionnaires (36 of whom attended the workshop). In a primary analysis including these 47 trainees, therapeutic intentions of tapering opioid maintenance for pain (in a paper-based clinical vignette) increased from 37 (80.4%) pre-intervention to 44 (95.7%) postintervention (P = 0.039). In a sensitivity analysis including only trainees attending the workshop, 80.0% pre-intervention and 97.1% postintervention tapered opioids (P = 0.070). Anticipated initiation of any opioids for a chronic osteoarthritic knee pain clinical vignette reduced from 35 (74.5%) to 24 (51.1%; P = 0.012) in the primary analysis and from 80.0% to 41.7% in the sensitivity analysis (P = 0.001). Necessary improvements in pain management and opioid harm avoidance are predicated on primary care education being of demonstrable efficacy. This brief educational intervention improved hypothetical management approaches two months subsequently. Further research measuring objective changes in physician behavior, especially opioid prescribing, is indicated.


  • The pattern of anxiolytic and hypnotic management by Australian general practice trainees

    by Simon M. Holliday, Simon Morgan, Amanda Tapley, Kim M. Henderson, Adrian J. Dunlop, Mieke L. van Driel, Neil A. Spike, Lawrence A. McArthur, Jean Ball, Christopher J. Oldmeadow, et al.

    Introduction and Aims: Guidelines recommend anxiolytics and hypnotics (A/H) as second‐line, short‐term medications. We aimed to establish prevalence and associations of A/H prescribing by Australian general practice (GP) trainees.Design and Methods: A cross‐sectional analysis from a cohort study of vocational trainees from four GP Regional Training Providers during 2010–2013. General practice trainees act as independent practitioners (including for prescribing purposes) while having recourse to advice from a GP supervisor. Practice and trainee demographic data were collected as well as patient, clinical and educational data from 60 consecutive consultations of each trainee each training term. Analysis was at the level of individual problem managed, with the outcome factor being prescription of any anxiolytic or hypnotic.Results: Overall, 645 registrars (response rate 94.0%) prescribed 68 582 medications in 69 621 consultations (with 112 890 problems managed). A/Hs were prescribed for 1.3% of problems managed and comprised 2.2% of all prescriptions. They were prescribed particularly for insomnia (28.2%) or anxiety (21.8%), but also for many ‘off‐label’ indications. Significant associations of A/H prescriptions were: patient‐level (greater age, Aboriginal and Torres Strait Islander status, English‐speaking background, being new to the trainee but not to the practice); trainee‐level (male) and consultation‐level (longer duration, pre‐existing problem, specialist referral not being made). Prescribing was significantly lower in one of the four Regional Training Providers.Discussion and Conclusions: GP trainees, inconsistent with most guideline recommendations, prescribe A/Hs mainly as maintenance therapy to unfamiliar and older patients. Our results suggest that changes in management approaches are needed which may be facilitated by support for psychotherapeutic training. [Holliday SM, Morgan S, Tapley A, Henderson KM, Dunlop AJ, van Driel ML, Spike NA, McArthur LA, Ball J, Oldmeadow CJ, Magin PJ. The pattern of anxiolytic and hypnotic management by Australian general practice trainees. Drug Alcohol Rev 2017;36:261-269].


  • Open Access

    The Pattern of Opioid Management by Australian General Practice Trainees

    by Simon Holliday, Simon Morgan, Amanda Tapley, Adrian Dunlop, Kim Henderson, Mieke van Driel, Neil Spike, Lawrie McArthur, Jean Ball, Chris Oldmeadow, et al.

    Objective. With escalating opioid prescribing come individual and public health harms. To inform quality improvement measures, understanding of opioid


  • Death due to intravenous use of α‐pyrrolidinopentiophenone

    by Simon M Holliday, Huy A Tran, FAChAM Simon M Holliday BMed, Frcpa Huy A Tran Fracp

  • An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy

    by Simon Holliday, Parker Magin, Christopher Oldmeadow, John Attia, Janet Dunbabin, Julie‐Marie Henry, Nicholas Lintzeris, Susan Goode, Adrian Dunlop

    Introduction.: Few general practitioners (GP) prescribe opioid substitution therapy. Our aim was to analyse their previously identified motivating factors by describing their frequency and demographic associations.Methods.: An anonymous, cross‐sectional questionnaire‐based survey on opioid prescribing in pain and dependency was distributed across five New South Wales Divisions of GPs. Questions elicited opinions on 11 barriers and five facilitators previously described in qualitative literature. Data were analysed against demographic variables, including opioid substitution therapy prescriber (OSTP) status and postgraduate training status. ‘Profiles’ of non‐OSTPs were then constructed using latent class analysis.Results.: Of the 1735 surveys posted, there were 404 responses (23.3%), with 16% respondents being OSTPs. Frequently reported barriers included: ‘negative experiences with the opioid dependent’ (72%), ‘heavy workload’ (60%) and ‘lack of specialist support’ (58%), with most barriers less frequent among OSTPs. Facilitating factors included: ‘more accessible specialist support’ (75%), ‘more accessible training’ (67%) and ‘better evidence of safety and efficacy’ (64%), with the latter two significantly less frequently among OSTPs. Latent class analysis of the non‐OSTPs revealed three distinct clusters. The smallest (‘class 3’) had the least barriers and resembled OSTPs demographically.Discussion and Conclusions.: The pattern of motivating factors towards the psychological, social and behavioural challenges of the management of dependency has a predominantly negative bias. However, this lessens with postgraduate training and OSTP experience. Structural and logistical options are identified to promote OSTP recruitment and retention. GPs resembling class 3 may be more amenable to becoming OSTPs and may be worth targeting for recruitment. [Holliday S, Magin P, Oldmeadow C, Dunbabin J, Henry J‐M, Lintzeris N, Attia J, Goode S, Dunlop A. An examination of the influences on New South Wales general practitioners regarding the provision of opioid substitution therapy. Drug Alcohol Rev 2013;32:495–503]


  • An Evaluation of the Prescription of Opioids for Chronic Nonmalignant Pain by Australian General Practitioners

    by Simon Holliday, Parker Magin, Janet Dunbabin, Christopher Oldmeadow, Julie-Marie Henry, Nicholas Lintzeris, John Attia, Susan Goode, Adrian Dunlop

    Our objective was to evaluate the quality of opioid analgesia prescribing in chronic nonmalignant pain (CNMP) by general practitioners (GPs, family physicians). An anonymous, cross-sectional questionnaire-based survey. The setting was five Australian divisions of general practice (geographically based associations of GPs). A questionnaire was mailed to all division members. Outcome measures were adherence to individual recommendations of locally derived CNMP practice guidelines. We received 404 responses (response rate 23.3%). In the previous fortnight, GPs prescribed long-term continuous opioids for CNMP for a median of 4 and a mean of 7.1 (±8.7) patients with CNMP. Guideline concordance (GLC) was poor, with no GP always compliant with all guideline items, and only 31% GPs usually employing most items. GLC was highest for the avoidance of high dosages or fast-acting formulations. It was lowest for strategies minimizing individual and public health harms, such as the initiation of opioids on a time-limited trial basis, use of contracts, and the preclusion or management of aberrant behaviors. GLC was positively associated with relevant training or qualifications, registration with the Australian Prescription Drug Monitoring Programme, being an opioid substitution therapy prescriber, and female gender. In this study, long-term opioids were frequently initiated for CNMP without a quality use-of-medicine approach. Potential sequelae are inadequate treatment of pain and escalating opioid-related harms. These data suggest a need for improved resourcing and training in opioid management across pain and addictions.